Merck
CN
Search Within
文件类型

212-222-7

应用筛选条件
关键词:'212-222-7'
显示 1-30 共 34 条结果 关于 "212-222-7" 范围 技术文档
Quality Control Range Sheet- MCY-112 and MCY2-212
IL-6 Control 1 107 – 222 pg/mL MKC Control 1 135 – 281 pg/mL Control 2 546 – 1133 pg/mL Control 2 698 – 1449 pg/mL
Quality Control Range Sheet- MCY-112 and MCY-212
IL-6 Control 1 107 – 222 pg/mL MKC Control 1 135 – 281 pg/mL Control 2 546 – 1133 pg/mL Control 2 698 – 1449 pg/mL
Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel
4742 pg/mL Control 2 570 - 1642 pg/mL M-CSF Control 1 98 - 204 pg/mL IL-15 Control 1 102 - 212 pg/mL RANTES Control 1 112 - 232 pg/mL Control 2
Data Sheet - S4946
man.1-7 Low expression is found in brain and liver. SOD3 is a tretrameric glycoprotein with a molecular weight ~30 kDa. The enzyme contains an 18 amino acid signal peptide preceding the 222 amino acids
Quality Control Range Sheet- MCC-115 and MCC-215
194 pg/mL LIX Control 1 107 - 222 pg/mL Control 2 478 - 993 pg/mL Control 2 472 - 980 pg/mL Control 2 530 - 1100 pg/mL G-CSF Control 1
XP725 Antibody Number-Lot Number 071M4826
274 275 276 3.4 205 206 207 208 229 230 231 232 253 254 255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237
MultiScreen Filter Plates with Ultracel®-10 Membrane
54 61 30 ABS 68 57 45 37 37 47 60 68 BSA 199 220 217 212 200 205 192 185 Buffer 208 235 226 228 227 223 212 193 Cyto c 199 237 226 210 221 222 211 196 FBS
Product Information - CSAA1
Transduction P y y n/d 197 Cdc7 Kinase C6613 Signal Transduction M y n/d n/d 198 PAK phospho (pS 212) Clone:PK-18 P3237 Signal Transduction M y y y 199 Phospholipase A2 group V P5242 Signal
LABORATORY NOTEBOOK ISSUANCE PAGE
–108 –17 0.55 7.6 212 1.407 Toluene 0.865 110.6 –93 4 0.59 2.4(25) 284 1.496 1,1,2–Trichlorotri#uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391
Lab Notebook Guidelines
–108 –17 0.55 7.6 212 1.407 Toluene 0.865 110.6 –93 4 0.59 2.4(25) 284 1.496 1,1,2–Trichlorotri#uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391
LABORATORY NOTEBOOK ISSUANCE PAGE
–108 –17 0.55 7.6 212 1.407 Toluene 0.865 110.6 –93 4 0.59 2.4(25) 284 1.496 1,1,2–Trichlorotri#uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391
LABORATORY NOTEBOOK ISSUANCE PAGE
–108 –17 0.55 7.6 212 1.407 Toluene 0.865 110.6 –93 4 0.59 2.4(25) 284 1.496 1,1,2–Trichlorotri#uoroethane 1.57 47–48 –35 — 0.69 — 231 1.358 2,2,4–Trimethylpentane 0.692 98–99 –107 –7 0.5 1.94 215 1.391
Principles of Steam-In-Place
2 20 20 38 60 108 148 241 413 575 983 30 30 57 90 162 222 362 619 863 1474 3 20 26 50 79 141 194 316 541 754 1287 30 40 75 118 212
App. Note Detection of pyrogens in hormone-based drugs
TEST. 211–212 (2015). 6. Associates of CAPE COD Incorporated. The New FDA Guidance for Industry “Pyrogen and Endotoxins Testing: Questions and Answers”. LAL Updat. 20, 1–4 (2002). 7. Wunderlich
Protocol- 03-0178-00
131 4 210 30 # 4 133 3 216 41 # 5 188 4 307 48 # 6 186 3 304 54 # 7 209 3 343 62 # 8 183 4 298 46 # 9 195 4 317 44
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
WB Pur Rb 50 µg AB3185 Anti-MEK1/2, phospho-specific (Ser218/222) H WB APur Rb 100 µL AB3810 Anti-MEK1/2, phospho-specific (Ser218/222) H WB APur Rb 25 µL AB3810-25UL Anti-MEK1, phospho-specific
Reprint: Industrial application of impurity flocculation to streamline antibody purification processes
microfiltration. Biotechnol. Bioeng. 88(7), 880–889 (2004). 23 Lydersen B, Brehm-Gibson T, Murel A. Acid precipitation of mammalian cell fermentation broth. Ann. NY Acad. Sci. 745, 222–231 (1994). 24 Chen J
Cytoskeletal Signaling Antibodies, Reagents and Kits
WB Pur Rb 50 µg AB3185 Anti-MEK1/2, phospho-specific (Ser218/222) H WB APur Rb 100 µL AB3810 Anti-MEK1/2, phospho-specific (Ser218/222) H WB APur Rb 25 µL AB3810-25UL Anti-MEK1, phospho-specific
Validation of Milliflex Quantum for bioburden testing of pharmaceutical products - PDA Journal of Pharmaceutical Science and Technology 2017 71 206-224 (Oliver Gordon et al)
Calculation was performed for each product solu- tion and each incubation condition (20 –25 °C on 212 PDA Journal of Pharmaceutical Science and Technology on June 29, 2017journal.pda.orgDownloaded
XP725 Antibody List Lot 129K4831
+Cy5 C0992 NA NA M 169 Ciliated Cell Marker C5867 NA NA M y n/d n/d 192 Anti Cy3+Cy5 C0992 NA NA M 212 Pan Cytokeratin C2931 NA NA M y y y 216 Anti Cy3+Cy5 C0992 NA NA M 225 Dnase I D0188 NA
XP725 Antibody List Lot 129K4830
+Cy5 C0992 NA NA M 169 Ciliated Cell Marker C5867 NA NA M y n/d n/d 192 Anti Cy3+Cy5 C0992 NA NA M 212 Pan Cytokeratin C2931 NA NA M y y y 216 Anti Cy3+Cy5 C0992 NA NA M 225 Dnase I D0188 NA
XP725 Antibody List Lot 089K4791
+Cy5 C0992 NA NA M 169 Ciliated Cell Marker C5867 NA NA M y n/d n/d 192 Anti Cy3+Cy5 C0992 NA NA M 212 Pan Cytokeratin C2931 NA NA M y y y 216 Anti Cy3+Cy5 C0992 NA NA M 225 Dnase I D0188 NA
Apoptosis - Antibodies, Reagents and Kits
IgG 250 µg 06-497 $319 Anti-PI 3-Kinase, p85, N-SH3, clone AB6 H M WB IP IC M IgG1κ 100 µg 05-212 $339 Anti-PI 3-Kinase, p85, N-SH2, clone UB93-3 H M R WB IP M IgG 200
User Guide Equinox SOP Software 2.1 for Windows XP
............................................. ii — Contenido 217 217 218 219 219 220 221 222 222 222 223 223 225 225 226 227 227 227 228 229 231 233 Capítulo 1 Instalación y
XP725 Worksheet for Lot Number 071M4826
Calreticulin C4606 207 2 1 2 7 Calretinin C7479 208 2 1 2 8 Calretinin C7479 209 2 1 3 1 Claspin C7867 210 2 1 3 2 Claspin C7867 211 2 1 3 3 CaM Kinase IV CaMKIV C2851 212 2 1 3 4 CaM
List of Antibodies
y n/d y 210 Cytokeratin peptide 18 C1399 M y n/d n/d 211 Cytokeratin peptide 19 C6930 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 M y n/d
3D BIOPRINTING: Printing a Brighter Future
behaviors such as these may soon become widespread in tissue engineering and tissue model engineering.210–212 Physical Properties Several physical properties must be considered for the clinical translation
3D BIOPRINTING: Printing a Brighter Future
behaviors such as these may soon become widespread in tissue engineering and tissue model engineering.210–212 Physical Properties Several physical properties must be considered for the clinical translation
XP725 Antibody List
KRT18 NP_954657.1 M y n/d n/d 211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y
XP725 Antibody List 013M4793
KRT18 NP_954657.1 M y n/d n/d 211 Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y
1/2